Delivery Order SPE2DB22D2005-SPE2DB25FJQD8
- Not listed
- The Defense Logistics Agency awarded a $11,463.02 delivery order to AmerisourceBergen Drug Corp for 1,440 units/mL of HAVRIX vaccine syringes on July 28, 2025, with completion targeted for July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,523.83 to AmerisourceBergen Drug Corp for the supply of 1,440 units of Havrix vaccine (1 ml syringes) with a completion date of June 30, 2025. This firm fixed-price contract, awarded on June 27, 2025, with no set-aside designation, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a competitive award to a critical pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of HAVRIX 1,440 Unit/ML Syringe vaccines valued at $1,339.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is scheduled for completion by August 7, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $10,140.60 to AmerisourceBergen Drug Corp for 1,440 units/mL of Havrix vaccine in syringe form. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure, with an ultimate completion date of July 21, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,703.84 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of HAVRIX 720 Unit/0.5 ML Syringe vaccines. The contract was awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency (DLA) awarded a $1,417.08 delivery order to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes, with an ultimate completion date of July 14, 2025. This firm fixed-price contract, awarded on July 11, 2025, is non-set-aside and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a $3,776.30 delivery order to AmerisourceBergen Drug Corp for Havrix 720 Unit/0.5 mL syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract represents a pediatric hepatitis A vaccine delivery through AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency has awarded a delivery order valued at $20,231.75 to AmerisourceBergen Drug Corp for the supply of 1,440 units/mL of HAVRIX vaccine in syringe form. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, awarded on August 4, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $33,589.80 delivery order to AmerisourceBergen Drug Corp for 1,440 units per milliliter of HAVRIX vaccine in syringe form. This competitively awarded, firm fixed price contract was executed on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified suppliers. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,490.36 to AmerisourceBergen Drug Corp for the supply of HAVRIX 1,440 Unit/ML vaccine syringes. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQD8Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,136.36 for 1,440 units/mL of HAVRIX vaccine syringes on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a single transaction under the company's larger pharmaceutical supply relationship with the federal government. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, medications, and medical devices across multiple therapeutic domains. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle that has demonstrated the company's capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 7/22/25 |